To report a rare case of malignant phyllodes tumor (PT) exhibiting both low-grade ductal carcinoma in situ (DCIS) and heterologous chondrosarcomatous differentiation, highlighting its clinical significance.
Key Findings:
Malignant PT with both DCIS and chondrosarcomatous differentiation is exceptionally rare, necessitating careful management.
The tumor displayed a biphasic architecture with distinct malignant components, raising questions about treatment strategies.
Adjuvant therapies were considered due to the presence of hormone receptor-positive DCIS, highlighting the complexity of treatment.
Interpretation:
The case highlights the diagnostic challenges and therapeutic considerations in managing complex tumors like malignant PT, emphasizing the need for extensive histopathological sampling and a multidisciplinary approach.
Limitations:
The rarity of the case limits generalizability and may introduce biases in treatment recommendations.
Long-term outcomes and optimal adjuvant therapy protocols remain unclear.
Conclusion:
This case underscores the importance of recognizing the dual malignant components in PTs for appropriate management and prognosis.
